Exploring how certain genes affect brain cell activity and fat processing in aging and Alzheimer's disease

Investigating the effects of APOE and APOE-related AD risk genes on human microglia activity and lipid metabolism in aging and disease

['FUNDING_OTHER'] · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · NIH-10900992

This study is looking at how certain genes, especially APOE, affect brain cells that help keep our brains healthy as we age and deal with Alzheimer's disease, with the hope of finding new ways to treat or prevent the condition.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (nih funded)
Locations1 site (NEW YORK, UNITED STATES)
Trial IDNIH-10900992 on ClinicalTrials.gov

What this research studies

This research investigates the role of specific genes, particularly APOE, in how brain cells called microglia respond to aging and Alzheimer's disease. It focuses on understanding how these cells manage cholesterol and lipid levels in the brain, which is crucial for maintaining brain health. By examining the genetic factors that influence microglial activity, the research aims to uncover potential therapeutic targets for Alzheimer's disease. Patients may benefit from insights that could lead to new treatments or preventive strategies for Alzheimer's.

Who could benefit from this research

Good fit: Ideal candidates for this research include older adults and individuals at risk for Alzheimer's disease, particularly those with genetic predispositions.

Not a fit: Patients with early-stage Alzheimer's disease or those without genetic risk factors for the condition may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches for Alzheimer's disease and improve brain health in aging individuals.

How similar studies have performed: Previous research has shown promising results in understanding the role of APOE in Alzheimer's disease, indicating that this approach has potential for significant findings.

Where this research is happening

NEW YORK, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.